Handelsavisen
prelaunch
Companies 002092.SZ
00
002092.SZ Shenzhen Stock Exchange Unclassified

Xinjiang Zhongtai Chemical Co Ltd

¥4,80
Open in Charts → Attach watcher ⌖
CNY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
12,4B CNY
P/E
EV / Rev
1,7x
Div yield
0,00 %
Op margin
-3,1 %
ROE
-4,1 %
Net margin
-3,1 %
Debt / equity
1,84
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Xinjiang Zhongtai Chemical Co Ltd operates in the chemicals industry within the materials sector, generating revenue through chemical manufacturing activities.

Business. Xinjiang Zhongtai Chemical Co Ltd operates in the chemicals industry within the materials sector, generating revenue through chemical manufacturing activities.

Classification20 %
SectorUnclassified
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-4,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 002092.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 002092.SZ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Xinjiang Zhongtai Chemical Co Ltd operates in the chemicals industry within the materials sector, generating revenue through chemical manufacturing activities.

    Classification20 %
    SectorUnclassified
    AI synthesis
    GENERATED

    The company exhibits a leveraged capital structure with a debt-to-equity ratio of 1.84, indicating significant reliance on debt financing relative to equity. Liquidity is constrained, evidenced by a current ratio of 0.45, which suggests potential short-term solvency pressures. Despite negative net income of -288.75 million CNY, the company generated positive operating cash flow of 3.25 billion CNY, though free cash flow remained negative at -569.60 million CNY due to capital expenditures of 2.98 billion CNY. The market capitalization of 10.10 billion CNY reflects a price-to-book ratio of 0.47, trading at a discount to tangible book value.

    Profitability metrics are currently negative, with a return on equity of -4.13% and a return on assets of -1.16%, reflecting operational losses in the latest period. The company reported an operating income of -118.72 million CNY on revenues of 28.70 billion CNY, resulting in a gross profit of 5.27 billion CNY. Without cohort median data for direct comparison, the negative returns indicate a period of financial stress or cyclical downturn within the chemical manufacturing sector. The enterprise value to EBITDA ratio is negative at -55.08, further highlighting the current unprofitability.

    Segment and geographic revenue breakdowns are not provided in the available data, preventing analysis of revenue concentration or specific business unit performance. The company's primary activity is identified as unclassified within the broader chemicals industry, limiting detailed operational insights.

    Growth trajectory analysis is hindered by the absence of historical period data, preventing assessment of revenue or net income trends over time. The current financial snapshot shows a single period of negative net income, but without historical context, the direction of growth cannot be determined.

    Risk assessment indicates medium liquidity risk and low dilution risk, with a key flag noting that net cash is negative after subtracting total debt. The company's total liabilities of 55.27 billion CNY exceed its total assets of 76.79 billion CNY, but the negative net cash position highlights potential refinancing or liquidity challenges. The current ratio of 0.45 reinforces the medium liquidity risk classification.

    Recent observations include an ESG score of 50.87 with a grade of B-, indicating moderate environmental, social, and governance performance. The environment pillar score is 56.48, while the social and governance pillars are 43.51 and 53.43, respectively. The ESG controversies score is 100, suggesting no significant recent controversies. No specific filing, news, or transcript observations are provided in the available data.

    Key takeaways
    • The company trades at a significant discount to book value with a P/B ratio of 0.47, reflecting market skepticism about current profitability.
    • High leverage with a debt-to-equity ratio of 1.84 and a low current ratio of 0.45 indicate elevated financial risk.
    • Positive operating cash flow of 3.25 billion CNY contrasts with negative free cash flow due to high capital expenditures.
    • Negative returns on equity and assets highlight current operational inefficiencies or cyclical headwinds.
    • Low dilution risk suggests stable share count, but liquidity risk remains medium due to negative net cash.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    Gross profit remained positive at 5.3 billion CNY in the latest period, indicating underlying production value despite operating losses.

    Revenue stabilized with a 5.0% year-over-year increase in the latest period, suggesting potential bottoming of top-line decline.

    Dilution risk is assessed as low, providing some protection for existing shareholders against equity value erosion.

    BEAR CASE · 3

    The company posted a net loss of 976.5 million CNY in the latest period, reflecting severe profitability deterioration.

    Free cash flow turned deeply negative at -1.87 billion CNY, signaling significant liquidity pressure and cash burn.

    Long-term debt surged to 35.1 billion CNY, creating a high credit risk profile and heavy leverage burden.

    In focus — financials by report

    Annual
    ANNUALFiled 2024-04-29
    FY 2024 · Full-year highlights

    Revenue ¥37.12B, −28,1% YoY; Operating income −313,1% YoY.

    Revenue¥37.12B−28,1 % YoY
    Operating income-¥3.15B−313,1 % YoY
    Net income-¥2.87B−469,1 % YoY
    Free cash flow-¥5.80B−113,2 % YoY
    EPS
    Operating cash flow¥4.17B−21,8 % YoY
    Financials
    Income statement
    Revenue¥37.12B
    Gross profit¥3.10B
    Operating income-¥3.15B
    Net income-¥2.87B
    Margins
    Gross margin8.3%
    Operating margin-8.5%
    Net margin-7.7%
    FCF margin-15.6%
    Balance sheet
    Total assets¥72.53B
    Total liabilities¥49.83B
    Total equity¥22.70B
    Cash & equivalents
    Long-term debt¥29.21B
    Cash flow
    Operating cash flow¥4.17B
    CapEx-¥4.27B
    Free cash flow-¥5.80B
    SBC
    P&L flow · revenue → net income
    Revenue ¥28.70BOperating costs ¥28.81BFinance ¥1.04BNet income ¥288.8M
    Highlights
    • Revenue ¥37.12B, −28,1% YoY
    • Operating income −313,1% YoY
    • Net income −469,1% YoY
    • Free cash flow −113,2% YoY
    • Net margin -7.7%

    Valuation FY

    Market price
    ¥4,80
    Market cap
    ¥10.10B
    Enterprise value
    ¥49.67B
    P/E
    Non-GAAP P/E
    EV / Revenue
    1.7x
    EV / Op income
    EV / OCF
    11.9x
    P / B
    0.5x
    P / Tangible book
    0.5x
    Tangible book
    ¥21.52B
    Net cash
    -¥39.57B
    Current ratio
    0.5
    Debt / equity
    1.8
    ROA
    -1.2%
    ROE
    -4.1%
    Cash conversion
    -468.0%
    CapEx / revenue
    -14.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Performance Chemicals
    low · llm_fanout_v2
    Specialty Chemicals & Products
    low · llm_fanout_v2

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-3,1 %Bottom quartile
    Net Margin-3,0 %Bottom quartile
    ROE-4,1 %Bottom quartile
    Capex / Rev-14,7 %Bottom quartile
    D/E1,84Bottom quartile
    Cash Conv-4,68Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    Source documents
    • Xinjiang Zhongtai Chemical Co Ltd Market data — financials · 2026-07-08
    • Xinjiang Zhongtai Chemical Co Ltd Market data — ESG · 2026-07-08

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    002092.SZCanonical
    Shenzhen Stock Exchange · CNY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2024-04-29 18:12 UTCEARNINGSAnnual results — FY 2024 Revenue CNY 37.12B · Net CNY -2.87B
    2023-03-30 18:42 UTCEARNINGSAnnual results — FY 2023 Revenue CNY 51.66B · Net CNY 776.3M
    2022-02-16 17:59 UTCEARNINGSAnnual results — FY 2022 Revenue CNY 62.89B · Net CNY 2.75B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage